These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2948912)

  • 21. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
    Frohlich ED
    Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of cardiac hypertrophy. Experimental animal model.
    Sen S
    Am J Med; 1983 Sep; 75(3A):87-93. PubMed ID: 6137950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The echocardiographic evolution of left ventricular hypertrophy in treated hypertensive patients. A long-term follow-up].
    Román O; Oyonarte M; Lioi X; Klenner TM
    Rev Esp Cardiol; 1991 Mar; 44(3):153-60. PubMed ID: 1828606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.
    Sugishita Y; Iida K; Yukisada K; Ito I
    J Am Coll Cardiol; 1990 Mar; 15(3):665-71. PubMed ID: 2137479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular adjustment to antiadrenergic agents.
    Pegram BL; Frohlich ED
    Am J Med; 1983 Sep; 75(3A):94-9. PubMed ID: 6137951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy and antihypertensive therapy.
    Graettinger WF; Weber MA
    Am Fam Physician; 1992 Aug; 46(2):483-91. PubMed ID: 1386180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
    Schmieder RE; Schlaich MP
    Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of regression of left ventricular hypertrophy in treated hypertensive patients.
    Wollam GL; Hall WD; Porter VD; Douglas MB; Unger DJ; Blumenstein BA; Cotsonis GA; Knudtson ML; Felner JM; Schlant RC
    Am J Med; 1983 Sep; 75(3A):100-10. PubMed ID: 6226186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An evaluation of the therapeutic trials aimed at regression of ventricular hypertrophy in arterial hypertension].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):503-8. PubMed ID: 1836942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular hypertrophy in patients with essential hypertension: outcome of 12 years antihypertensive treatment.
    Shigematsu S; Hiramatsu K; Aizawa T; Yamada T; Takasu N; Niwa A; Miyahara Y; Tsujino M; Shimizu Z
    Cardiology; 1990; 77(4):280-6. PubMed ID: 1981491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.
    Dahlöf B; Pennert K; Hansson L
    Am J Hypertens; 1992 Feb; 5(2):95-110. PubMed ID: 1532319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preserved ventricular pump function after a marked reduction of left ventricular mass.
    Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
    J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.
    Drayer JI; Weber MA; Gardin JM; Lipson JL
    Am J Med; 1983 Sep; 75(3A):116-20. PubMed ID: 6226188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats.
    Matsubara H; Yamamoto J; Hirata Y; Mori Y; Oikawa S; Inada M
    Circ Res; 1990 Jan; 66(1):176-84. PubMed ID: 2136812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.
    Betocchi S; Chiariello M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S116-21. PubMed ID: 1381787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.